Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
Public ClinicalTrials.gov record NCT00649792. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months in patients who previously participated in the MS-F204 study or until it becomes commercially available, whichever comes first.
Study identification
- NCT ID
- NCT00649792
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2007 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Apr 2011 (Actual)
- Last update posted
- Feb 28, 2012
2007 – 2011
United States locations
- U.S. sites
- 38
- U.S. states
- 25
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| HOPE Research Institute | Phoenix | Arizona | 85050 | — |
| Neurological Associates | Fayetteville | Arkansas | 72703 | — |
| Alta Bates Summit Medical Center - Research and Education Institute | Berkeley | California | 94705 | — |
| USC, Keck School of Medicine Health Care Consultation Center | Los Angeles | California | 90033 | — |
| UC Davis | Sacramento | California | 95817 | — |
| Yale University MS Center | New Haven | Connecticut | 06510 | — |
| Shepherd Center | Atlanta | Georgia | 30309 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Consultants in Neurology, Ltd. | Northbrook | Illinois | 60062 | — |
| Indiana University MS Center | Indianapolis | Indiana | 46202 | — |
| Associates in Neurology, PSC | Lexington | Kentucky | 40503 | — |
| Maryland Center for MS | Baltimore | Maryland | 21201 | — |
| Lahey Clinic | Lexington | Massachusetts | 02421 | — |
| Wayne State University, Department of Neurology | Detroit | Michigan | 48201 | — |
| The Schapiro Center for MS | Golden Valley | Minnesota | 55422 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Advanced Neurology Specialists | Great Falls | Montana | 59405 | — |
| UMDNJ | Newark | New Jersey | 07103 | — |
| Gimbel MS Center at Holy Name Hospital | Teaneck | New Jersey | 07666 | — |
| Jacobs Neurological Institute Buffalo General Hospital | Buffalo | New York | 14203 | — |
| Corinne Goldsmith Dickinson Center for MS | New York | New York | 10029 | — |
| Columbia University Multiple Sclerosis Clinical Care Center | New York | New York | 10032 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| SUNY Stony Brook | Stony Brook | New York | 11794 | — |
| CMC - Neuroscience & Spine Institute, Division of Neurology | Charlotte | North Carolina | 28207 | — |
| Raleigh Neurology Associates | Raleigh | North Carolina | 27607 | — |
| Wake Forest University, Dept of Neurology, M.S. Research | Winston-Salem | North Carolina | 27157 | — |
| The Center for Neurological Services | Bismarck | North Dakota | 58501 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Ohio State University MS Center | Columbus | Ohio | 43221 | — |
| Oregon Health & Science University, MS Center of Oregon, UHS-42 | Portland | Oregon | 97239 | — |
| Thomas Jefferson University Physicians | Philadelphia | Pennsylvania | 19107 | — |
| Neurological Research Center, Inc. | Bennington | Vermont | 05201 | — |
| Fletcher Allen Health Care | Burlington | Vermont | 05401 | — |
| MS Center at Evergreen | Kirkland | Washington | 98034 | — |
| CAMC Health Education & Research Institute | Charleston | West Virginia | 25304 | — |
| Center for Neurological Disorders of Aurora, St. Luke's Medical Center | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00649792, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2012 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00649792 live on ClinicalTrials.gov.